William Phelan
Net worth: 1 M $ as of 2024-03-30
Profile
William L.
Phelan worked as the Chief Accounting Officer & Senior Vice President at MiMedx Group, Inc. from 2020 to 2023.
Prior to that, he worked as the Chief Accounting Officer & Vice President at Sancilio Pharmaceuticals Co., Inc. Mr. Phelan holds an MBA from The Pennsylvania State University and an undergraduate degree from Shippensburg University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MIMEDX GROUP, INC.
0.13% | 2023-05-09 | 184,219 ( 0.13% ) | 1 M $ | 2024-03-30 |
Former positions of William Phelan
| Companies | Position | End |
|---|---|---|
| MIMEDX GROUP, INC. | Comptroller/Controller/Auditor | 2023-08-31 |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Comptroller/Controller/Auditor | - |
Training of William Phelan
| The Pennsylvania State University | Masters Business Admin |
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MIMEDX GROUP, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
- Stock Market
- Insiders
- William Phelan
